Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035

Johann Kuhn,1 Valérie Olié,2 Clémence Grave,2 Yann Le Strat,1 Christophe Bonaldi,1 Pierre Joly1,3 1Data Science Division, French National Public Health Agency, Saint-Maurice, France; 2Department of Chronic Diseases and Injuries, French National Public Health Agency, Saint-Maurice, France; 3Centre Inserm U1219 – Bordeaux Population Health, Université de Bordeaux – ISPED, Bordeaux, FranceCorrespondence: Johann Kuhn, Email [email protected]: Myocardial infarction (MI) is a cardiovascular disease caused by necrosis of the myocardium, which places a heavy burden on patients. In France, the proportion of daily smokers remains high, reaching at 25.5% in 2020. We evaluated the impact of smoking reduction scenarios on the projection of MI prevalence, mean age of incident cases and number of MI prevented cases until 2035.Methods and Results: The French government has introduced smoking cessation policies that have led to an annual decrease in smoking prevalence. Based on this annual decline, we implemented three scenarios (SC) simulating an annual decrease in the proportion of smokers aged over 35 (SC1: 1%, ie, natural evolution without intervention, SC2: 2%, SC3: 9.87%) and a fourth scenario (SC4) in which there is a complete discontinuation of smoking from 2024 onwards using MI hospitalization and demographic data, estimations for the proportion of daily smokers between 35 and 95 years and multi-state models. Between 2023 and 2035, MI prevalence increased from 3.18% to 4.23% in males and from 1.00% to 1.46% in females under SC1. MI prevalence was equal to 4.21%, 4.06%, and 3.82% in males and 1.45%, 1.40%, and 1.34% in females in 2035 according to SC2, SC3, and SC4, respectively. Compared with SC1, 0.68% MI cases would be prevented with SC2, 4.52% with SC3 and 10.34% with SC4, with almost half of cases being prevented before 65 years of age. The increase in the mean age of MI incident cases ranged from 3 to 4 years among males and from 1 to 2 years among females.Conclusion: While reducing tobacco use could substantially reduce the number of MI cases prevented, its prevalence would continue to increase due to the ageing population. An integrated prevention strategy that includes the leading cardiovascular risk factors should more efficiently reduce the future burden of MI.Keywords: myocardial infarction, prevalence, burden, projection, tobacco control, smoking prevalence

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-09-01
Primary Topic
Health Services Management and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035

SHILAP Revista de lepidopterología
Health Services Management and Policy
article

Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035

article en

Abstract

Johann Kuhn,1 Valérie Olié,2 Clémence Grave,2 Yann Le Strat,1 Christophe Bonaldi,1 Pierre Joly1,3 1Data Science Division, French National Public Health Agency, Saint-Maurice, France; 2Department of Chronic Diseases and Injuries, French National Public Health Agency, Saint-Maurice, France; 3Centre Inserm U1219 – Bordeaux Population Health, Université de Bordeaux – ISPED, Bordeaux, FranceCorrespondence: Johann Kuhn, Email [email protected]: Myocardial infarction (MI) is a cardiovascular disease caused by necrosis of the myocardium, which places a heavy burden on patients. In France, the proportion of daily smokers remains high, reaching at 25.5% in 2020. We evaluated the impact of smoking reduction scenarios on the projection of MI prevalence, mean age of incident cases and number of MI prevented cases until 2035.Methods and Results: The French government has introduced smoking cessation policies that have led to an annual decrease in smoking prevalence. Based on this annual decline, we implemented three scenarios (SC) simulating an annual decrease in the proportion of smokers aged over 35 (SC1: 1%, ie, natural evolution without intervention, SC2: 2%, SC3: 9.87%) and a fourth scenario (SC4) in which there is a complete discontinuation of smoking from 2024 onwards using MI hospitalization and demographic data, estimations for the proportion of daily smokers between 35 and 95 years and multi-state models. Between 2023 and 2035, MI prevalence increased from 3.18% to 4.23% in males and from 1.00% to 1.46% in females under SC1. MI prevalence was equal to 4.21%, 4.06%, and 3.82% in males and 1.45%, 1.40%, and 1.34% in females in 2035 according to SC2, SC3, and SC4, respectively. Compared with SC1, 0.68% MI cases would be prevented with SC2, 4.52% with SC3 and 10.34% with SC4, with almost half of cases being prevented before 65 years of age. The increase in the mean age of MI incident cases ranged from 3 to 4 years among males and from 1 to 2 years among females.Conclusion: While reducing tobacco use could substantially reduce the number of MI cases prevented, its prevalence would continue to increase due to the ageing population. An integrated prevention strategy that includes the leading cardiovascular risk factors should more efficiently reduce the future burden of MI.Keywords: myocardial infarction, prevalence, burden, projection, tobacco control, smoking prevalence

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 34%
Health Services Management and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.